CA Stock MarketDetailed Quotes
AVBT Avisa Diagnostics Inc
- 0.045
- 0.0000.00%
15min DelayMarket Closed Apr 12 09:30 ET
123.66KMarket Cap-197P/E (TTM)
0.000High0.000Low0Volume0.000Open0.045Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio2.75MShares0.00052wk Low-0.228EPS TTM123.66KFloat Cap0.000Historical HighLossP/E (Static)2.75MShs Float0.000Historical Low-0.177EPS LYR0.00%Amplitude--Dividend TTM-0.12P/B1Lot Size--Div YieldTTM
Avisa Diagnostics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -266.77%-582.34K | -35.63%-288.25K | 66.41%-452.28K | 115.91%25.82K | 59.41%-106.8K | 47.34%-158.78K | 65.70%-212.53K | 31.85%-1.35M | 74.92%-162.31K | 59.90%-263.14K |
| Net income from continuing operations | -1,162.38%-4.53M | 1,012.77%1.19M | 82.69%-715.76K | 95.24%-105.83K | 78.56%-120.95K | 48.66%-358.95K | 79.96%-130.04K | 36.36%-4.13M | 13.56%-2.22M | -4.19%-564.07K |
| Operating gains losses | ---61.58K | ---1.86M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 15.78%6.36K | -39.80%3.31K | -97.93%20.03K | -98.42%3.83K | -97.85%5.21K | -97.72%5.49K | -97.71%5.5K | -20.02%965.67K | -79.93%242.34K | --242.34K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 187.64%1.49M | ---- | ---- |
| Remuneration paid in stock | 81.30%12.55K | 27.30%21.15K | -76.60%31.31K | 101.59%372 | -89.87%7.41K | -76.56%6.92K | -69.52%16.61K | -37.00%133.79K | -111.73%-23.32K | --73.08K |
| Other non cashItems | --3.78M | --386.71K | -59.24%17.1K | --42.94K | ---29.04K | ---- | ---- | -98.33%41.94K | ---- | ---- |
| Change In working capital | 7.59%198.57K | 73.85%-27.36K | 21.67%195.05K | -72.98%84.51K | 311.00%30.57K | 45.28%184.57K | 60.53%-104.6K | 148.06%160.31K | 55,750.71%312.76K | 87.37%-14.49K |
| -Change in receivables | ---- | ---- | 427.85%63.9K | -99.65%166 | 125.69%4.52K | 58.99%102.65K | 61.85%-43.43K | 68.19%-19.49K | 332.07%47.41K | -117.67%-17.61K |
| -Change in prepaid assets | -355.42%-48.94K | 91.68%-4.72K | -98.34%256 | -1.99%18.63K | 1,594.55%19.19K | 214.27%19.16K | -572.56%-56.72K | 184.40%15.39K | 356.59%19.01K | -56.20%-1.28K |
| -Change in payables and accrued expense | 251.56%247.51K | -422.31%-22.64K | 3.23%150K | -74.51%65.71K | 126.21%6.86K | 24.87%70.4K | 104.92%7.02K | 0.81%145.3K | 807.89%257.81K | 87.75%-26.17K |
| -Change in other working capital | ---- | ---- | -200.00%-19.11K | --0 | --0 | ---7.64K | ---11.47K | --19.11K | ---11.47K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -266.77%-582.34K | -35.63%-288.25K | 66.41%-452.28K | 115.91%25.82K | 59.41%-106.8K | 47.34%-158.78K | 65.70%-212.53K | 31.85%-1.35M | 74.92%-162.31K | 59.90%-263.14K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 88.99%-27.92K | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | --0 | -34.50%-27.92K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 88.99%-27.92K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 584.15K | -1.14M | 144.35K | -55.12K | 0 | 0 | 0 | 0 | ||
| Net issuance payments of debt | ---109.43K | ---30K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | --240 | ---1.11M | --144.35K | ---55.12K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --584.15K | ---1.14M | --144.35K | ---55.12K | --0 | ---- | ---- | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -113.22%-28.64K | 228.14%1.4M | -76.34%426.27K | -75.35%145.23K | -70.19%253.97K | -81.47%216.63K | -76.34%426.27K | 409.65%1.8M | -75.39%589.28K | -72.05%851.95K |
| Current changes in cash | 210.71%126.41K | -571.61%-1.43M | 77.59%-307.94K | 81.95%-29.29K | 59.41%-106.8K | 112.90%40.69K | 66.45%-212.53K | -194.63%-1.37M | 72.29%-162.31K | 59.90%-263.14K |
| Effect of exchange rate changes | ---- | ---- | -1,039.12%-8.33K | -746.93%-5.94K | -516.59%-1.93K | -77.41%-3.35K | 107.54%2.89K | 83.85%-731 | 90.70%-701 | -82.72%464 |
| End cash Position | -61.57%97.6K | -113.22%-28.64K | -74.19%110K | -74.19%110K | -75.35%145.23K | -70.19%253.97K | -81.47%216.63K | -76.34%426.27K | -76.34%426.27K | -75.39%589.28K |
| Free cash from | -266.77%-582.34K | -35.63%-288.25K | 67.09%-452.28K | 115.91%25.82K | 59.41%-106.8K | 49.67%-158.78K | 66.45%-212.53K | 38.82%-1.37M | 73.08%-162.31K | 59.90%-263.14K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data